A proof-of-concept trial evaluating the effects of Relief Therapeutics’ antimicrobial wound spray RLF-TD011 — formerly known as APR-TD011…
Articles by Patricia Inácio, PhD
From sharing images and information on social media, to holding fundraisers to spread the word about epidermolysis bullosa (EB), supporters…
Squamous cell carcinoma (SCC), a type of skin cancer well known in people with recessive dystrophic epidermolysis bullosa (RDEB),…
Krystal Biotech is seeking U.S. Food and Drug Administration (FDA) approval of Vyjuvek (previously called B-VEC), its topical gene…
Tetra Bio-Pharma’s investigational cannabinoid cream PPP004 (THC-CBD) has been granted orphan drug status by the European Medicines Agency (EMA)…
Vitamin D supplements are necessary to increase and normalize the vitamin’s levels in the blood of children with recessive…
At-home inhalation of nitrous oxide, a colorless gas commonly used for sedation, may help reduce pain during wound dressings in…
Pain, but not wound size, significantly affects a person’s perception of disease severity with dominant dystrophic epidermolysis bullosa (DEB),…
The U.S. Food and Drug Administration (FDA) has extended by three months its review of Amryt Pharma’s application seeking approval…
A Phase 2 trial into the safety and early efficacy of INM-755, a cannabinol cream for people with epidermolysis bullosa…
HMP Global’s Symposium on Advanced Wound Care (SAWC) Fall has established partnerships with the Wound Healing Foundation and…
Malnutrition, both moderate and severe, is fairly common among children with epidermolysis bullosa (EB) living in India, a study suggests. A…